Atrial fibrillation - European Society of Cardiology
... incidence of atrial fibrillation in subjects over 22 years was 2%, being slightly more common in men (2·2%) than in women (1·7%). The prevalence was 0·5% for subjects in the age range 50–59 years and 8·8% in subjects in the age range 80–89 years. The more recent Cardiovascular Health Study on Americ ...
... incidence of atrial fibrillation in subjects over 22 years was 2%, being slightly more common in men (2·2%) than in women (1·7%). The prevalence was 0·5% for subjects in the age range 50–59 years and 8·8% in subjects in the age range 80–89 years. The more recent Cardiovascular Health Study on Americ ...
Non-contact Tonometry Synchronized with Cardiac Rhythm and its
... non-contact tonometer (Nidek Co. Ltd., Gamagori, Japan). Inclusion criteria required that the subjects did not suffer from any current eye disease or injury, except ocular hypertension or glaucoma. However, despite some subjects presenting with IOP higher than 20 mmHg, there were no clinical signs o ...
... non-contact tonometer (Nidek Co. Ltd., Gamagori, Japan). Inclusion criteria required that the subjects did not suffer from any current eye disease or injury, except ocular hypertension or glaucoma. However, despite some subjects presenting with IOP higher than 20 mmHg, there were no clinical signs o ...
atrial arrhythmogenesis during myocardial infarction
... Clinical studies................................................................................................................. 39 ...
... Clinical studies................................................................................................................. 39 ...
ACC/AHA Guidelines for Coronary Angiography
... The executive summary and recommendations are published in the May 4, 1999, issue of Circulation. The full text is published in the Journal of the American College of Cardiology. Reprints of both the full text and the executive summary and recommendations are available from both organizations. These ...
... The executive summary and recommendations are published in the May 4, 1999, issue of Circulation. The full text is published in the Journal of the American College of Cardiology. Reprints of both the full text and the executive summary and recommendations are available from both organizations. These ...
and the role of cardiac resynchronization therapy
... In patients, LBBB has been associated with LV dilatation, hypertrophy and reduced LV ejection fraction,9 as well as myocardial perfusion defects.18 However, in all of these studies LBBB patients have considerable co-morbidity, hampering the conclusion that these abnormalities are related to dyssynch ...
... In patients, LBBB has been associated with LV dilatation, hypertrophy and reduced LV ejection fraction,9 as well as myocardial perfusion defects.18 However, in all of these studies LBBB patients have considerable co-morbidity, hampering the conclusion that these abnormalities are related to dyssynch ...
Exercise Standards for Testing and Training A Scientific Statement
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
Exercise Standards for Testing and Training
... divided by LV wall thickness), contractility, and HR.1,4 Accurate measurement of myocardial oxygen uptake requires cardiac catheterization to obtain coronary arterial and venous oxygen content. However, myocardial oxygen uptake can be estimated during clinical exercise testing by the product of HR a ...
... divided by LV wall thickness), contractility, and HR.1,4 Accurate measurement of myocardial oxygen uptake requires cardiac catheterization to obtain coronary arterial and venous oxygen content. However, myocardial oxygen uptake can be estimated during clinical exercise testing by the product of HR a ...
AHA guidelines - Boston University Medical Campus
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
Exercise Standards for Testing and Training A Scientific Statement
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
2013 Exercise Standards for Testing and Training
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
... dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremental rise in HR during a progressive exercise test could be attributed to an enhanced level of fitness and left ventricular (LV ...
atrial fibrillation
... Atrial fibrillation is typically seen in patients who have common cardiovascular diseases such as hypertension and heart failure or who have lifestyle risk factors such as alcohol and or obesity. It is a significant cause of morbidity and mortality, the presence of atrial fibrillation increases the ...
... Atrial fibrillation is typically seen in patients who have common cardiovascular diseases such as hypertension and heart failure or who have lifestyle risk factors such as alcohol and or obesity. It is a significant cause of morbidity and mortality, the presence of atrial fibrillation increases the ...
atrial fibrillation
... Atrial fibrillation is treated in order to increase the quality of life, decrease the frequency and intensity of symptoms, and decrease the risk of complications and death. Unfortunately, there is no conclusive evidence that the therapies available reduce the mortality rate associated with atrial fi ...
... Atrial fibrillation is treated in order to increase the quality of life, decrease the frequency and intensity of symptoms, and decrease the risk of complications and death. Unfortunately, there is no conclusive evidence that the therapies available reduce the mortality rate associated with atrial fi ...
Regulation of Coronary Blood Flow During Exercise
... Duncker DJ, Bache RJ. Regulation of Coronary Blood Flow During Exercise. Physiol Rev 88: 1009 –1086, 2008; doi:10.1152/physrev.00045.2006.—Exercise is the most important physiological stimulus for increased myocardial oxygen demand. The requirement of exercising muscle for increased blood flow neces ...
... Duncker DJ, Bache RJ. Regulation of Coronary Blood Flow During Exercise. Physiol Rev 88: 1009 –1086, 2008; doi:10.1152/physrev.00045.2006.—Exercise is the most important physiological stimulus for increased myocardial oxygen demand. The requirement of exercising muscle for increased blood flow neces ...
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the
... 8.5. Primary Prevention . . . . . . . . . . . . . . . . . . . . . . . . .e171 9. Proposed Management Strategies. . . . . . . . . . . . .e172 9.1. Overview of Algorithms for Management of Patients With Atrial Fibrillation . . . . . . . . . . . . .e172 9.1.1. Newly Discovered Atrial Fibrillation . . . ...
... 8.5. Primary Prevention . . . . . . . . . . . . . . . . . . . . . . . . .e171 9. Proposed Management Strategies. . . . . . . . . . . . .e172 9.1. Overview of Algorithms for Management of Patients With Atrial Fibrillation . . . . . . . . . . . . .e172 9.1.1. Newly Discovered Atrial Fibrillation . . . ...
Bicuspid Aortic Valve Associated With Aortic Dilatation A Community
... individuals who had aortic coarctation or concomitant hypertension, a known risk factor for aortic dilatation and dissection.1,4 – 8 Moreover, other large necropsy series of aortic dissection found no association with BAV in the patients studied.9 Nonetheless, the presence of BAV in patients with fa ...
... individuals who had aortic coarctation or concomitant hypertension, a known risk factor for aortic dilatation and dissection.1,4 – 8 Moreover, other large necropsy series of aortic dissection found no association with BAV in the patients studied.9 Nonetheless, the presence of BAV in patients with fa ...
ACC/AHA/ESC Practice Guidelines
... unchanged recommendations has not been updated. It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies as they are introduced and tested in the detection, management, or prevention of disease states. Rigorous and ex ...
... unchanged recommendations has not been updated. It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies as they are introduced and tested in the detection, management, or prevention of disease states. Rigorous and ex ...
ACC/AHA/ESC 2006 guidelines for the management
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
ACC/AHA/ESC guidelines for the management of patients with atrial
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
2016 ESC Guidelines for the management of atrial fibrillation
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
2016 ESC Guidelines for the management of atrial fibrillation
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
ACC/AHA/ESC Practice Guidelines
... This document was approved by the American College of Cardiology Foundation Board of Trustees in June 2006; by the American Heart Association Science Advisory and Coordinating Committee in June 2006; and by the European Society of Cardiology Committee for Practice Guidelines in June 2006. When this ...
... This document was approved by the American College of Cardiology Foundation Board of Trustees in June 2006; by the American Heart Association Science Advisory and Coordinating Committee in June 2006; and by the European Society of Cardiology Committee for Practice Guidelines in June 2006. When this ...
Antihypertensive drug
Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used drugs are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.Which type of medication to use initially for hypertension has been the subject of several large studies and resulting national guidelines. The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. The several classes of antihypertensives differ in side effect profiles, ability to prevent endpoints, and cost. The choice of more expensive agents, where cheaper ones would be equally effective, may have negative impacts on national healthcare budgets. As of 2009, the best available evidence favors the thiazide diuretics as the first-line treatment of choice for high blood pressure when drugs are necessary. Although clinical evidence shows calcium channel blockers and thiazide-type diuretics are preferred first-line treatments for most people (from both efficacy and cost points of view), an ACE inhibitor is recommended by NICE in the UK for those under 55 years old.